(19)
(11) EP 4 770 624 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24776343.6

(22) Date of filing: 28.08.2024
(51) International Patent Classification (IPC): 
A61K 31/00(2006.01)
A61P 29/02(2006.01)
A61P 35/00(2006.01)
A61P 25/00(2006.01)
A61P 31/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/658; A61P 29/02; A61P 31/04; A61P 35/00; A61P 25/00
(86) International application number:
PCT/IB2024/058371
(87) International publication number:
WO 2025/046489 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.08.2023 US 202363579731 P

(71) Applicant: BT DE Investments Inc.
Wilmington, DE 19803 (US)

(72) Inventors:
  • RIVERA, Andrea
    London EC2R 3LA (GB)
  • BEN KHALED, Sara
    London WC2R 3LA (GB)
  • BAILLO, Andrea
    Roxboro, North Carolina 27574 (US)

(74) Representative: D Young & Co LLP 
3 Noble Street
London EC2V 7BQ
London EC2V 7BQ (GB)

   


(54) 5-OH CBC FOR USE IN THERAPY AND NON-THERAPEUTIC USES THEREOF